Next |
home / stock / lpcn / lpcn message board
Subject | By | Source | When |
---|---|---|---|
$LPCN short squeeze signal | RunninRobert | investorshub | 05/12/2023 7:26:37 AM |
Bottom was in on the eighth | Triple nickle | investorshub | 05/11/2023 4:27:09 PM |
Added | Triple nickle | investorshub | 05/11/2023 4:25:38 PM |
Time for this to show some returns | gi197845 | investorshub | 05/11/2023 4:04:56 AM |
$LPCN Found an interesting article | gi197845 | investorshub | 05/10/2023 6:49:32 PM |
The now last up | gi197845 | investorshub | 05/08/2023 5:31:32 PM |
$LPCN Time for this to show some returns | gi197845 | investorshub | 05/08/2023 6:00:54 AM |
$LPCN here we go bulls news is here | Vance | investorshub | 05/07/2023 6:08:29 PM |
$LPCN The gaining | BesaoT35 | investorshub | 05/07/2023 4:27:08 AM |
$LPCN MomentumIts gaining | gi197845 | investorshub | 05/06/2023 10:16:15 PM |
$LPCN just the news we needed | gi197845 | investorshub | 05/06/2023 4:41:30 PM |
$LPCN The gaining | gi197845 | investorshub | 05/05/2023 10:34:06 PM |
$LPCN bulls and bears | gi197845 | investorshub | 05/05/2023 1:09:47 PM |
Price trading | gi197845 | investorshub | 05/04/2023 7:06:18 PM |
$LPCN got some short data | Vance | investorshub | 05/04/2023 10:57:37 AM |
short squeeze signal | Vance | investorshub | 05/03/2023 11:32:28 AM |
$LPCN Price now | BesaoT35 | investorshub | 05/01/2023 8:44:43 PM |
$LPCN Price trading | Vance | investorshub | 05/01/2023 5:24:58 PM |
best news of the day | Pyramid2 | investorshub | 04/30/2023 9:41:01 PM |
$LPCN MomentumIts now | gi197845 | investorshub | 04/30/2023 4:50:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study PR Newswire Met standard bioequivalence (BE) criteria C max, AUC 0-t , and AUC 0- ∞ C trough criterion was met LPCN 1154 was well tolerat...
Shares of Lipocine Inc. (NASDAQ: LPCN) traded at a new 52-week high today and are currently trading at $8.96. So far today, approximately 78,318 shares have been exchanged, as compared to an average 30-day volume of 32,701 shares. Lipocine Inc., a clinical-stage biopharmaceutical company, foc...
Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024 PR Newswire SALT LAKE CITY , June 10, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that Phase 2 r...